About: Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.70 (+3.30%)
UPB NASDAQ Upstream Bio, Inc.
Upstream Bio, Inc. share price
UPB price activity
Last Price
$4.700
Change (24hr)
0.15 USD (3.30%)
Volume
1.17M
Volume (4w avg)
-
Open
$4.54
Day Range
$4.52 - $4.76
Previous Close
$4.55
Last Trade
09 Oct, 8:00 pm GMT+0
Delayed
09 Oct, 8:00 pm GMT+0
UPB price performance
Delayed
09 Oct, 8:00 pm GMT+0
UPB Market Signals